DEFECTIVE PLATELET DISAGGREGATION ASSOCIATED WITH OCCLUSIVE ARTERIAL DISEASES
- The determination of the 99th centile level for troponin assays in an Australian reference population. Tate, Jillian R.; Ferguson, Wendy; Bais, Renze; Kostner, Karam; Marwick, Thomas; Carter, Andrew // Annals of Clinical Biochemistry;May2008, Vol. 45 Issue 3, p275
Background: Current guidelines for the diagnosis and risk assessment of patients presenting with myocardial infarction recommend a single decision cut-off point for cardiac troponin (cTn) based on the 99th centile of a reference population. The 99th centile level for eight troponin assays was...
- Make room for aspirin in secondary MI prevention. Pinkowish, Mary Desmond // Patient Care;5/30/1996, Vol. 30 Issue 10, p14
Focuses on the use of aspirin in aftercare of elderly patients with myocardial infarction. Positive effects of aspirin on mortality.
- Antiplatelet Therapy in Peripheral Arterial Disease. Aronow, Wilbert S. // Current Drug Targets - Cardiovascular & Haematological Disorders;Sep2004, Vol. 4 Issue 3, p265
Antiplatelet therapy significantly reduces the incidence of vascular death, nonfatal myocardial infarction, and nonfatal stroke in patients with peripheral arterial disease (PAD) and intermittent claudication, in patients undergoing peripheral grafting, in patients undergoing peripheral...
- Clopidogrel cost effective for prevention of vascular events? // PharmacoEconomics & Outcomes News;8/14/2004, Issue 459, p9
Discusses research being done on the costs of clopidogrel treatment for secondary prevention of vascular events among patients with peripheral arterial disease, a stroke, or either of these in combination with a prior myocardial infarction. Reference to a study by M. D. Schleinitz, et al...
- PLASMA FIBRINOGEN AND SERUM ALDOLASE IN ACUTE MYOCARDIAL INFARCTION. Losner, Samuel; Volk, Bruno W. // Angiology;Oct1956, Vol. 7 Issue 5, p454
Focuses on the study determining the factors causing the rise of the concentration of plasma fibrinogen in the body. Effects of myocardial infarction on the health several individuals; Increase on the risks of death; Description on the physical condition of various patients.
- Combining PPI and aspirin increases CVD event risk. // Pulse;6/8/2011, Vol. 71 Issue 21, p9
The article reports on the result of the study which suggests that prescribing proton-pump inhibitors to myocardial infarction patients on aspirin can increase their risk of cardiovascular events.
- Primary or rescue PCI? // Heart;Jun2008, Vol. 94 Issue 6, p819
The article presents a study on the primary percutaneous coronary intervention (PCI) as a treatment for ST elevation myocardial infarction (STEMI). The study used networks of non-PCI centers as spokes and PCI centers as hubs in Poland, Italy, and France. STEMI patients were referred to hubs and...
- ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised... Baigent, Colin; Collins, Rory; Appleby, Paul; Parish, Sarah; Sleight, Peter; Peto, Richard // BMJ: British Medical Journal (International Edition);05/02/98, Vol. 316 Issue 7141, p1337
Presents a study which looks at the effects of intravenous streptokinase and oral aspirin, on survival in patients with suspected acute myocardial infarction. Detailed information on patients and methodologies used in the study; Results of the study; Discussion on the study.
- Low Incidence of Myocardial Infarction Following Femoral-Popliteal Bypass. Rubio, Pedro A.; Farrell, Edward M.; Guinn, Gene A. // Vascular Surgery;Sep/Oct1979, Vol. 13 Issue 5, p322
Ninety-five consecutive male patients had a total of 114 femoral-popliteal bypasses in 5-year period. A clinical diagnosis of coronary artery disease was made in 24 of the patients (25.3%). None of the patients with or without coronary artery disease developed postoperative myocardial...